Membership

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy. It is SITC's mission to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation, leadership and diversity and inclusion in the field.

Member CategoriesMember BenefitsApplication Requirements Join/Renew

Membership Term

SITC membership terms span January 1 through December 31. Membership dues are paid annually and cover the calendar year. SITC membership dues are nonrefundable and non-transferable.

Developing Economy Rate

Members in developing economies, as defined by the World Bank, are eligible for reduced rates. This discount is available in the membership application but does not apply to those in industry.

Join or Renew

Help improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy. Join or renew your SITC membership today.

Questions or Concerns

We'd love to hear from you! If you have questions about becoming a SITC member or renewing your membership, please email the society at membership@sitcancer.org or call +1 414-271-2456.

Why I'm a SITC Member

Member Categories & Application Requirements

To apply for SITC membership, please submit your curriculum vitae or résumé. Student applicants must provide yearly proof of attendance (letter of offer, student id, transcripts) and a letter of recommendation or curriculum vitae.

Member Benefits

Whether seeking to expand your professional network, receive discounted rates to exemplary meetings, stay current with the field via SITC meeting presentations or more, a SITC membership provides value to all experience levels.

Exclusive Access and Savings to SITC Live Events

Personal and Professional Advancement Opportunities

Education Resources and Savings

Annual Funding and Awards Opportunities

Keeping You Informed

  • FDA cancer immunotherapy approval confirmation emails
  • Scientific meeting coverage emails
  • Quarterly SITC policy e-newsletter